New synergistic combination therapy approaches with HDAC inhibitor quisinostat, cisplatin or PARP inhibitor talazoparib for urothelial carcinoma
Article in Journal of Cellular and Molecular Medicine (May 2024)
The most recent citing publications are shown below. View all 45 publications that cite this research output on Dimensions.
Article in Journal of Cellular and Molecular Medicine (May 2024)
Article in Medical Oncology (June 2023)
Article in Journal of Personalized Medicine (October 2022)